Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Liabilities and Compensation

v3.24.1.u1
Accounts Payable and Accrued Liabilities and Compensation
9 Months Ended
Feb. 29, 2024
Accounts Payable and Accrued Liabilities and Compensation  
Accounts Payable and Accrued Liabilities and Compensation

Note 3. Accounts Payable and Accrued Liabilities and Compensation

As of February 29, 2024, and May 31, 2023, the accounts payable balance was approximately $62.1 million and $62.7 million, respectively, with two vendors accounting for 71% and 72% of the total balance of accounts payable at the respective dates.

The components of accrued liabilities and compensation are as follows (in thousands):

February 29, 2024

May 31, 2023

Compensation and related expense

$

186

$

335

Legal fees and settlement

112

168

Clinical expense

355

187

Accrued inventory charges and expenses

 

7,899

 

4,978

License fees

1,565

862

Lease payable

142

139

Investor proceeds held in escrow

300

Total accrued liabilities

$

10,559

$

6,669